Tag: RAN

Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies

The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago, and the University of Toronto have expanded a previous research collaboration with Bristol Myers Squibb, aimed to create and develop high-performance recombinant antibodies against diverse targets in human cells.

The RAN was founded in 2012 by …

Continue reading